-
Je něco špatně v tomto záznamu ?
Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes
M. Krátký, E. Novotná, S. Saxena, P. Yogeeswari, D. Sriram, M. Švarcová, J. Vinšová,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT13346
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2000
Hindawi Publishing Open Access
od 2000-01-01
PubMed Central
od 2000
Europe PubMed Central
od 2000
ProQuest Central
od 2012-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2012-01-03
Medline Complete (EBSCOhost)
od 2012-01-01
Health & Medicine (ProQuest)
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
25538961
DOI
10.1155/2014/703053
Knihovny.cz E-zdroje
- MeSH
- antituberkulotika chemie MeSH
- bakteriální proteiny * antagonisté a inhibitory chemie MeSH
- inhibitory enzymů chemie MeSH
- Mycobacterium tuberculosis enzymologie MeSH
- salicylanilidy chemie MeSH
- simulace molekulového dockingu * MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Antimycobacterially active salicylanilide diethyl phosphates were evaluated to identify their potential drug target(s) for the inhibition of several mycobacterial enzymes, including isocitrate lyase, L-alanine dehydrogenase (MtAlaDH), lysine ε-aminotransferase, chorismate mutase, and pantothenate synthetase. The enzymes are related to the nongrowing state of Mycobacterium tuberculosis. Salicylanilide diethyl phosphates represent new candidates with significant inhibitory activity especially against L-alanine dehydrogenase. The most active MtAlaDH inhibitor, 5-chloro-2-[(3-chlorophenyl)carbamoyl]phenyl diethyl phosphate, has an IC50 of 4.96 µM and the best docking results. Other mycobacterial enzymes were mostly inhibited by some derivatives but at higher concentrations; isocitrate lyase showed the highest resistance to salicylanilide diethyl phosphates.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000425
- 003
- CZ-PrNML
- 005
- 20181212134152.0
- 007
- ta
- 008
- 160108s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2014/703053 $2 doi
- 035 __
- $a (PubMed)25538961
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Krátký, Martin $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. $7 jo2017947786
- 245 10
- $a Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes / $c M. Krátký, E. Novotná, S. Saxena, P. Yogeeswari, D. Sriram, M. Švarcová, J. Vinšová,
- 520 9_
- $a Antimycobacterially active salicylanilide diethyl phosphates were evaluated to identify their potential drug target(s) for the inhibition of several mycobacterial enzymes, including isocitrate lyase, L-alanine dehydrogenase (MtAlaDH), lysine ε-aminotransferase, chorismate mutase, and pantothenate synthetase. The enzymes are related to the nongrowing state of Mycobacterium tuberculosis. Salicylanilide diethyl phosphates represent new candidates with significant inhibitory activity especially against L-alanine dehydrogenase. The most active MtAlaDH inhibitor, 5-chloro-2-[(3-chlorophenyl)carbamoyl]phenyl diethyl phosphate, has an IC50 of 4.96 µM and the best docking results. Other mycobacterial enzymes were mostly inhibited by some derivatives but at higher concentrations; isocitrate lyase showed the highest resistance to salicylanilide diethyl phosphates.
- 650 _2
- $a antituberkulotika $x chemie $7 D000995
- 650 12
- $a bakteriální proteiny $x antagonisté a inhibitory $x chemie $7 D001426
- 650 _2
- $a inhibitory enzymů $x chemie $7 D004791
- 650 12
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a Mycobacterium tuberculosis $x enzymologie $7 D009169
- 650 _2
- $a salicylanilidy $x chemie $7 D012458
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Novotná, Eva $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Saxena, Shalini $u Medicinal Chemistry Research Laboratory, Pharmacy Group, Birla Institute of Technology and Science, Hyderabad 500078, India.
- 700 1_
- $a Yogeeswari, Perumal $u Medicinal Chemistry Research Laboratory, Pharmacy Group, Birla Institute of Technology and Science, Hyderabad 500078, India.
- 700 1_
- $a Sriram, Dharmarajan $u Medicinal Chemistry Research Laboratory, Pharmacy Group, Birla Institute of Technology and Science, Hyderabad 500078, India.
- 700 1_
- $a Švarcová, Markéta $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Vinšová, Jarmila, $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. $d 1951- $7 nlk19990073991
- 773 0_
- $w MED00181094 $t TheScientificWorldJournal $x 1537-744X $g Roč. 2014, č. - (2014), s. 703053
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25538961 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20181212134316 $b ABA008
- 999 __
- $a ok $b bmc $g 1102706 $s 924631
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 2014 $c - $d 703053 $e 20141104 $i 1537-744X $m TheScientificWorldJournal $n ScientificWorldJournal $x MED00181094
- GRA __
- $a NT13346 $p MZ0
- LZP __
- $a Pubmed-20160108